Decentralized Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Decentralized Clinical Trials in Mexico

Decentralized Clinical Trials in Mexico – Clinical Trials in LATAM

In recent years, the field of clinical research has undergone a significant transformation with the advent of decentralized clinical trials (DCTs). These trials leverage technology to bring medical research to patients’ homes, offering numerous advantages over traditional site-based trials.

Mexico, with its diverse population and growing healthcare infrastructure, has emerged as an ideal setting for the implementation of decentralized clinical trials. In this blog, we will explore the benefits, challenges, and future prospects of decentralized clinical trials in Mexico.

Accessibility and Patient-Centric Approach


One of the primary advantages of decentralized clinical trials is the improved accessibility to research opportunities for patients. In Mexico, a decentralized approach can bridge the gap between patients and clinical trials by eliminating the need for travel to distant research sites.


This patient-centric model enhances diversity in study populations, as it enables participation from individuals residing in remote areas or with limited mobility. By reducing barriers to entry, decentralized trials in Mexico have the potential to attract a more diverse pool of participants, leading to more inclusive and representative research outcomes.


Cost-Efficiency and Enhanced Recruitment


Traditional clinical trials often incur substantial costs related to infrastructure, site management, and patient reimbursements. In Mexico, where financial resources can be limited, decentralized trials offer a more cost-effective alternative. By leveraging telemedicine, wearables, and remote monitoring technologies, researchers can collect data remotely, reducing the need for frequent site visits and associated expenses.


Furthermore, decentralized trials facilitate enhanced patient recruitment by expanding the geographic reach and enabling greater participation from previously untapped regions, thereby accelerating the trial timelines and reducing recruitment challenges.


Real-World Data and Ecological Validity


Decentralized clinical trials provide a unique opportunity to collect real-world data in Mexico. By conducting trials in patients’ everyday environments, researchers can capture a more accurate representation of the impact of treatments on patients’ lives. This approach enhances ecological validity and allows for the evaluation of treatment effectiveness in a broader context.


The integration of digital health technologies, such as mobile apps and connected devices, enables continuous monitoring, providing valuable insights into patient experiences and treatment outcomes.


Decentralized Clinical Trials in Mexico

Decentralized Clinical Trials in Mexico

Decentralized Clinical Trials in Mexico

Regulatory Considerations

For decentralized clinical trials to thrive in Mexico, a supportive regulatory framework is essential. Regulatory authorities in Mexico have recognized the importance of embracing innovative trial designs and are working to create an environment that fosters the growth of decentralized trials.

Collaborative efforts between regulators, healthcare providers, and sponsors can streamline the approval process, ensuring adherence to ethical guidelines while maintaining patient safety and data integrity.

Overcoming Challenges

While decentralized clinical trials offer numerous benefits, they also present unique challenges. Digital literacy, connectivity issues, and privacy concerns can hinder participation in remote research. In Mexico, addressing these challenges requires investment in digital infrastructure, patient education programs, and robust data protection measures. Collaboration among stakeholders is crucial to ensure that the benefits of decentralized trials are accessible to all segments of the population.

Collaboration and Stakeholder Engagement


The success of decentralized clinical trials in Mexico relies on effective collaboration and engagement among various stakeholders. These include researchers, healthcare providers, regulatory bodies, technology providers, and patient advocacy groups.

Establishing strong partnerships and open lines of communication is essential for designing and implementing decentralized trials that meet the needs of both patients and researchers. By working together, stakeholders can address challenges, share best practices, and collectively drive the adoption of decentralized trial models in Mexico.


Decentralized clinical trials hold immense promise for advancing medical research and transforming healthcare in Mexico. By embracing innovative trial designs, leveraging technology, and fostering collaboration, Mexico can create an environment conducive to decentralized trials.

Through enhanced accessibility, cost-efficiency, and real-world data collection, decentralized trials have the potential to improve patient outcomes, accelerate drug development, and promote a more inclusive and patient-centric approach to clinical research in Mexico. As the healthcare landscape continues to evolve, decentralized trials stand at the forefront of innovation, shaping the future of clinical research in Mexico and beyond.

Decentralized Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Decentralized Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Decentralized Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Decentralized Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Decentralized Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Decentralized Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Decentralized Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Decentralized Clinical Trials in Mexico

The Cohortias Team

Decentralized Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Decentralized Clinical Trials in Mexico

Network & Partnerships